Who Owns GLMD?

Galmed Pharmaceuticals Ltd. — Institutional Ownership & 13F Holdings

$0.57

+0.00 (+0.00%)

Market Cap

$3.4M

Shares Outstanding

5,479,230

Institutional Holders

13

Total Inst. Value

$80K

% of Float Held

QoQ Holder Change

+2

Institutional data as of Q1 2025

New Positions

5

Closed Positions

2

Increased

0

Decreased

4

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1Schonfeld Strategic Advisors LLC$36K25,194
2Virtu Financial LLCNew$16K11,126
3TWO SIGMA SECURITIES, LLCNew$16K11,019
4MORGAN STANLEY$10K7,385
5UBS Group AG$2K1,104
6SBI Securities Co., Ltd.$2316
7WELLS FARGO & COMPANY/MN$139
8OSAIC HOLDINGS, INC.$75
9Allworth Financial LP$42
10ELEVATION WEALTH PARTNERS, LLCNew$21

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

Related Stocks

Frequently Asked Questions

How many institutional investors hold GLMD?

As of Q1 2025, 13 institutional investors report holding GLMD (Galmed Pharmaceuticals Ltd.) in their 13F filings.

Which hedge fund owns the most GLMD?

The largest institutional holder of GLMD is Schonfeld Strategic Advisors LLC with $36K in shares.

Are institutions buying or selling GLMD?

This quarter, 5 institutions opened new positions in GLMD and 2 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.